CONTROLLED CLINICAL TRIALS OF ATYPICAL NEUROLEPTICS

非典型神经阻滞剂的对照临床试验

• 批准号: 6301956
• 负责人: STEPHEN ROBERT SCHROEDER
• 金额: $ 16.01万
• 依托单位: UNIVERSITY OF KANSAS LAWRENCE
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-01-01 至 2000-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6301956
• 关键词: aggression; behavior disorders; behavioral /social science research tag; clinical research; clinical trials; clozapine; cognition; disease /disorder proneness /risk; dosage; extrapyramidal disorder; human subject; human therapy evaluation; instinct; memory; mental disorder chemotherapy; mental retardation; outcomes research; psychomotor function; psychopharmacology; risperidone; self destructive behavior; aggression; behavior disorders; behavioral /social science research tag; clinical research; clinical trials; clozapine; cognition; disease /disorder proneness /risk; dosage; extrapyramidal disorder; human subject; human therapy evaluation; instinct; memory; mental disorder chemotherapy; mental retardation; outcomes research; psychomotor function; psychopharmacology; risperidone; self destructive behavior

暂无数据